Skip to content

Clinical trials

Phase 3 Gastrointestinal Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 3 Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20161
20191
20201
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Société des Produits Nestlé (SPN)2
Amgen1
Anthos Therapeutics, Inc.1
AstraZeneca1
GlaxoSmithKline1
Pfizer1
Sumitomo Pharma America, Inc.1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms9
Colorectal Neoplasms4
Digestive System Diseases3
Digestive System Neoplasms3
Gastrointestinal Diseases3
Intestinal Diseases3
Intestinal Neoplasms3
Neoplasms by Site3
Rectal Diseases3
Colonic Diseases2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.